- Home
- CR vs BRKR Comparison
CR vs BRKR Comparison
Compare CR & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CR
- BRKR
- Stock Information
- Founded
- CR 1855
- BRKR 1991
- Country
- CR United States
- BRKR United States
- Employees
- CR N/A
- BRKR N/A
- Industry
- CR Metal Fabrications
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- CR Industrials
- BRKR Industrials
- Exchange
- CR Nasdaq
- BRKR Nasdaq
- Market Cap
- CR 8.5B
- BRKR 9.9B
- IPO Year
- CR N/A
- BRKR 2000
- Fundamental
- Price
- CR $142.18
- BRKR $64.88
- Analyst Decision
- CR Strong Buy
- BRKR Buy
- Analyst Count
- CR 6
- BRKR 10
- Target Price
- CR $164.00
- BRKR $80.11
- AVG Volume (30 Days)
- CR 158.3K
- BRKR 917.3K
- Earning Date
- CR 10-21-2024
- BRKR 10-31-2024
- Dividend Yield
- CR 0.58%
- BRKR 0.31%
- EPS Growth
- CR 25.57
- BRKR 10.49
- EPS
- CR 4.15
- BRKR 2.39
- Revenue
- CR $2,209,500,000.00
- BRKR $3,119,700,000.00
- Revenue This Year
- CR $79.54
- BRKR $17.05
- Revenue Next Year
- CR N/A
- BRKR $9.19
- P/E Ratio
- CR $34.25
- BRKR $26.76
- Revenue Growth
- CR 11.07
- BRKR 14.93
- 52 Week Low
- CR $82.57
- BRKR $53.79
- 52 Week High
- CR $162.34
- BRKR $94.86
- Technical
- Relative Strength Index (RSI)
- CR 38.46
- BRKR 53.59
- Support Level
- CR $152.05
- BRKR $63.57
- Resistance Level
- CR $158.62
- BRKR $68.85
- Average True Range (ATR)
- CR 3.53
- BRKR 1.77
- MACD
- CR -0.86
- BRKR 0.17
- Stochastic Oscillator
- CR 0.15
- BRKR 45.25
About CR Crane Company
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into three segments: aerospace and electronics, process flow technologies, and engineered materials. Crane generated approximately $2.1 billion in revenue in 2023.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.